MINNEAPOLIS--(BUSINESS WIRE)--MGI PHARMA, INC. (NASDAQ:MOGN), a biopharmaceutical company focused in oncology and acute care, today announced it has received two awards for product innovation and revenue growth. The Company was named a 2006 Minnesota Tekne Award winner in the Established Biotechnology category, and was ranked 212th on the Deloitte Technology Fast 500 list for North America.
